• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therap (NQ: CAPR )

    5.240 -0.090 (-1.69%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 210,194
    Open 5.400
    Bid (Size) 5.160 (1)
    Ask (Size) 5.440 (100)
    Prev. Close 5.330
    Today's Range 5.180 - 5.400
    52wk Range 2.680 - 8.221
    Shares Outstanding 31,399,667
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Recap: Capricor Therapeutics Q4 Earnings
    Via Benzinga
    Earnings Scheduled For February 29, 2024
    Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
    Via Benzinga

    Performance

    YTD
    +2.34%
    +2.34%
    1 Month
    -26.15%
    -26.15%
    3 Month
    +29.70%
    +29.70%
    6 Month
    +87.14%
    +87.14%
    1 Year
    +39.36%
    +39.36%

    More News

    Read More
    Capricor Therapeutics's Earnings Outlook
    Via Benzinga
    Preview: Capricor Therapeutics's Earnings
    Via Benzinga
    FlexShopper And 3 Other Penny Stocks Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Turn Lower; Dow Tumbles Over 200 Points
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Recap: Capricor Therapeutics Q1 Earnings
    Via Benzinga
    Earnings Preview For Capricor Therapeutics
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Top 5 Health Care Stocks That May Fall Off A Cliff
    Via Benzinga
    Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study
    Via Benzinga
    Earnings Scheduled For March 15, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
    Via Benzinga
    Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
    Via Benzinga
    Capricor Initiates Late-Stage Neuropsychiatric Disorder Study
    Via Benzinga
    More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
    Via Benzinga
    7 Undervalued Penny Stocks With Major Upside
    Via InvestorPlace
    50 Biggest Movers From Yesterday
    Via Benzinga
    Mid-Afternoon Market Update: Dow Drops 150 Points; Capricor Therapeutics Shares Plunge
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.